Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for ...

Camizestrant with a CDK 4/6 inhibitor had a statistically significant and clinically meaningful improvement in PFS in ...

Chemoradiation improves survival in cervical cancer patients, but benefits may decline after age 80, according to a study ...

I was told my lymphoma had worsened, but a miraculous turn of events spared me from aggressive chemotherapy, making me ...

Dr. Chandler Park helps patients with genitourinary cancers, including both prostate and bladder, understand the importance ...

For female patients with glioma, pregnancy after receiving a diagnosis of glioma is associated with worse progression-free ...

After realizing that a stronger support system would have helped me emotionally and spiritually in my cancer journey, I ...

Fractionated reirradiation is safe and feasible, suggesting higher reirradiation dose may be feasible in patients with ...

Datroway demonstrated durable antitumor activity and an acceptable safety profile in advanced NSCLC with actionable genomic ...

The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients ...

Metronomic capecitabine plus an aromatase inhibitor improved survival outcomes in hormone receptor-positive, HER2-negative ...

Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.